M-Ras, a widely expressed 29-kD homologue of p21 Ras: Expression of a constitutively active mutant results in factor-independent growth of an interleukin-3-dependent cell line

Blood

Volumn 94, Issue 7, 1999, Pages 2433-2444

  Ehrhardt, Götz R A ^a   Leslie, Kevin B ^a   Lee, Frances ^a   Wieler, James S ^a   Schrader, John W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 3; MONOCLONAL ANTIBODY; RAS PROTEIN; RECOMBINANT INTERLEUKIN 4;

ANIMAL CELL; ARTICLE; CAENORHABDITIS ELEGANS; CELL TRANSFORMATION; FIBROBLAST CULTURE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN; THYMUS;

EID: 0033214221     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.7.2433.419k31_2433_2444     Document Type: Article

References (51)

1. Egan SE, Weinberg RA: The pathway to signal achievement [news]. Nature 365:781, 1993
2. Moodie SA, Wolfman A: The 3Rs of life: Ras, Raf and growth regulation. Trends Genet 10:44, 1994
3. Trent JC, 2nd, McConkey DJ, Loughlin SM, Harbison MT, Fernandez A, Ananthaswamy HN: Ras signaling in tumor necrosis factor-induced apoptosis. EMBO J 15:4497, 1996
4. Boguski MS, McCormick F: Proteins regulating Ras and its relatives. Nature 366:24602, 1994
5. Milburn MV, Tong L, deVos AM, Brunger A, Yamaizumi Z, Nishimura S, Kim SH: Molecular switch for signal transduction: Structural differences between active and inactive forms of protooncogenic ras proteins. Science 247:939, 1990
6. Leevers SJ, Paterson HFm Marshall CJ: Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369:411, 1994
7. Stokoe D, Macdonald SG, Cadwallader K, Symons M, Hancock JF: Activation of Raf as a result of recruitment to the plasma membrane [see comments] [published erratum appears in Science 266:2792, 1994]. Science 264:1463, 1994
8. Stokoe D, Macdonald SG, Cadwallader K, Symons M, Hancock JF: Activation of Raf as a result of recruitment to the plasma membrane [see comments] [published erratum appears in Science 266:2792, 1994]. Science 264:1463, 1994
9. Russell M, Lange-Carter CA, Johnson, GL: Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1). J Biol Chem 270:11757, 1995
10. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J: Phosphatidylinositol-3-OH kinase as a direct target of Ras [see comments]. Nature 370:527, 1994
11. Hofer F, Fields S, Schneider C, Martin GS: Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc Natl Acad Sci USA 91:11089, 1994
12. Joneson T, White MA, Wigler MH, Bar-Sagi D: Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS. Science 271:810, 1996
13. Scheffzek K, Ahmadian MR, Kabsch W, Wiesmuller L, Lautwein A, Schmitz F, Wittinghofer A: The Ras-RasGAP complex: Structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 277:333, 1997
14. Sweetenham JW: Mutated genes in myeloid leukemias. Exp Hematol 22:5, 1994
15. Bos JL: ras oncogenes in human cancer: A review [published erratum appears in Cancer Res 50:1352, 1990]. Cancer Res 49:4682, 1989
16. Bos JL: ras oncogenes in human cancer: A review [published erratum appears in Cancer Res 50:1352, 1990]. Cancer Res 49:4682, 1989
17. Johnson L, Greenbaum D, Cichowski K, Mercer K, Murphy E, Schmitt E, Bronson RT, Umanoff H, Edelmann W, Kucherlapati R, Jacks T: K-ras is an essential gene in the mouse with partial functional overlap with N-ras [published erratum appears in Genes Dev 11:3277, 1997] . Genes Dev 11:2468, 1997 Duronio V, Welham MJ, Abraham S, Dryden P, Schrader JW: p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. Proc Natl Acad Sci USA 89:1589, 1992
18. Johnson L, Greenbaum D, Cichowski K, Mercer K, Murphy E, Schmitt E, Bronson RT, Umanoff H, Edelmann W, Kucherlapati R, Jacks T: K-ras is an essential gene in the mouse with partial functional overlap with N-ras [published erratum appears in Genes Dev 11:3277, 1997] . Genes Dev 11:2468, 1997 Duronio V, Welham MJ, Abraham S, Dryden P, Schrader JW: p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. Proc Natl Acad Sci USA 89:1589, 1992
19. Johnson L, Greenbaum D, Cichowski K, Mercer K, Murphy E, Schmitt E, Bronson RT, Umanoff H, Edelmann W, Kucherlapati R, Jacks T: K-ras is an essential gene in the mouse with partial functional overlap with N-ras [published erratum appears in Genes Dev 11:3277, 1997] . Genes Dev 11:2468, 1997 Duronio V, Welham MJ, Abraham S, Dryden P, Schrader JW: p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. Proc Natl Acad Sci USA 89:1589, 1992
20. Satoh T, Nakafuku M, Miyajima A, Kaziro Y: Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, inlerleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. Proc Natl Acad Sci USA 88:3314, 1991
21. Downward J, Graves JD, Warne PH, Rayter S, Cantrell DA: Stimulation of p21 ras upon T-cell activation. Nature 346:719, 1990
22. Lazarus AH, Kawauchi K, Papoport MJ, Delovitch TL: Antigen-induced B lymphocyte activation involves the p21ras and ras.GAP signaling pathway. J Exp Med 178:1765, 1993
23. Okuda K, Ernst TJ, Griffin JD: Inhibition of p21ras activation blocks proliferation but not differentiation of interleukin-3-dependent myeloid cells. J Biol Chem 269:24602, 1994
24. Swan KA, Alberola-Ila J, Gross JA, Appleby MW, Forbush KA, Thomas JF, Perlmutter RM: Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J 14:276, 1995
25. Iritani BM, Forbush KA, Farrar MA, Perlmutter RM: Control of B cell development by Ras-mediated activation of Raf. EMBO J 16:7019, 1997
26. Sigal IS, Gibbs JB, D' Alonzo JS, Scolnick EM: Identification of effector residues and a neutralizing epitope of Ha-ras-encoded p21. Proc Natl Acad Sci USA 83:4725, 1986
27. Koide H, Satoh T, Nakafuku M, Kaziro Y: GTP-dependent association of Raf-1 with Ha-Ras: Identification of Raf as a target downstream of Ras in mammalian cells. Proc Natl Acad Sci USA 90:8683, 1993
28. Mulcahy LS, Smith MR, Stacey DW: Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 313:241, 1985
29. Feig LA, Cooper GM: Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol Cell Biol 8:3235, 1988
30. de Vries-Smits AM, Burgering BM, Leevers SJ, Marshall CJ, Bos JL: Involvement of p21ras in activation of extracellular signal-regulated kinase 2 [see comments]. Nature 357:602, 1992
31. Lange-Carter CA, Johnson GL: Ras-dependent growth factor regulation of MEK kinase in PC12 cells. Science 265:1458, 1994
32. Lowe DG, Capon DJ, Delwart E, Sakaguchi AY, Naylor SL, Goeddel DV: Structure of the human and murine R-ras genes, novel genes closely related to ras proto-oncogenes. Cell 48:137, 1987
33. Drivas GT, Shin A, Coutavas E, Rush MG, D'Eustachio P: Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line. Mol Cell Biol 10:1793, 1990
34. Matsumoto K, Asano T, Endo T: Novel small GTPase M-Ras participates in reorganization of actin cytoskeleton. Oncogene 15:2409, 1997
35. Kimmelman A, Tolkacheva T, Lorenzi MV, Osada M, Chan AM: Identification and characterization of R-ras3: A novel member of the RAS gene family with a non-ubiquitous pattern of tissue distribution. Oncogene 15:2675, 1997
36. Panina-Bordignon P, Tan A, Termijtelen A, Demotz S, Corradin G, Lanzavecchia A: Universally immunogenic T cell epitopes: Promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol 19:2237, 1989
37. Schrader JW, Crapper RM: Autogenous production of a hemopoietic growth factor, persisting cell stimulating factor, as a mechanism for transformation of bone-marrow-derived cells. Proc Natl Acad Sci USA 80:6892, 1983
38. Shaw MK, Lorens JB, Dhawan A, DalCanto R, Tse HY, Tran AB, Bonpane C, Eswaran SL, Brocke S, Sarvetnick N, Steinman L, Nolan GP, Fathman CG: Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med 185:1711, 1997
39. Karasuyama H, Melchers F: Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol 18:97, 1988
40. Taylor SJ, Shalloway D: Cell cycle-dependent activation of Ras. Curr Biol 6:1621, 1996
41. Levings MK, Bessette DC, Schrader JW: Interleukin-4 synergizes with Raf-1 to promote long-term proliferation and activation of c-jun N-terminal kinase. Blood 93:3694, 1999
42. Hill CS, Treisman R: Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 80:199, 1995
43. Satoh T, Endo M, Nakafuku M, Nakamura S, Kaziro Y: Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells. Proc Natl Acad Sci USA 87:5993, 1990
44. Stacey DW, Feig LA, Gibbs JB: Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras. Mol Cell Biol 11:4053, 1991
45. Boriack-Sjodin PA, Margarit SM, Bar-Sagi D, Kuriyan J: The structural basis of the activation of Ras by Sos. Nature 394:337, 1998
46. Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PG: Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360:689, 1992
47. Welham M, Duronio V, Sanghera J, Pelech S, Schrader JW: Multiple hemopoietic growth factors stimulate activation of MAP-kinase family members. J Immunol 149:1683, 1992
48. Foltz IN, Schrader JW: Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of Interleukin-4. Blood 89:3092, 1997
49. Foltz IN, Lee JC, Young PR, Schrader, JW: Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway. J Biol Chem 272:1377, 1997
50. Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M: Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 17:5598, 1997
51. Olson MF, Paterson HF, Marshall CJ: Signals from Ras and Rho GTPases interact to regulate expression of p21 Waf1/Cip1. Nature 394:295, 1998